Pages

Showing posts with label Neuro ICU. Show all posts
Showing posts with label Neuro ICU. Show all posts

Thursday, January 14, 2016

Nonthrombolytic therapy for patients who are not candidates for rTPA after ischemic stroke


TARGET: 

✔️optimization of CBF

✔️prevention of secondary brain injury, infarct extension & hemorrhagic conversion 

✔️avoid post-stroke complications (e.g., pulmonary embolus and aspiration pneumonia)

✔️ early mobilization and rehabilitation

✔️ attention to psychiatric ( e.g. Depression) and social consequences of stroke and assistance with daily activities.


(1) Airway management, hemodynamic monitoring, and treatment of increased ICP 

(2) aggressive antihypertensive therapy may exacerbate ischemia by decreasing CBF. A generally accepted cutoff for the administration of antihypertensive therapies is SBP >220 mm Hg, DBP >120 mm Hg, or MAP >130 mm Hg. 

(3) In the absence of hemorrhage on a CT scan, antiplatelet therapy is initiated in the form of aspirin starting with 325 mg by mouth followed by 81 to 160 mg daily.

(4) Multiple studies have failed to show a benefit to heparin administration ; but anticoagulation is usually initiated when atrial fibrillation is present.

(5) Hyperglycemia worsens neurologic outcome. So , euglycemia (80 to 110 mg/dL) is beneficial if it can be achieved without substantially increasing the risk of hypoglycemia.

(6) Seizures are treated with phenytoin, loading dose 15 mg/kg i.v. over 20 minutes followed by 5 to 7 mg/kg/day, or fosphenytoin, loading dose PE 15 to 20 mg/kg i.v., and then 4 to 6 PE mg/kg/day.

(7) DVT prophylaxis is provided using pneumatic compression or low-molecular-weight heparin e.g. enoxaparin, 0.5 mg/kg subcutaneously twice a day.

(8) After the evaluation of airway reflexes and adequacy of swallowing, nutrition is provided via a suitable route.

(9) A few studies suggest that positioning the head end of the bed at 15° for patients who have normal ICP improves CBF and neurologic function.

(10) Rehabilitation and psychiatric evaluation. e.g. Treatment of depression and other psychiatric comorbidities facilitates rehabilitation and improves functional status.

Ref: Seth Manoach, Jean G. Charchaflieh, Handbook of Neuroanesthesia, 4th Edition, Lippincott Williams & Wilkins

Saturday, December 26, 2015

CHASING THE ICP..SORRY CHASING THE WELLNESS OF THE BRAIN❗️



📛In the absence of disease, ICP may rise by 50 mmHg during coughing or sneezing without noticeable neur ologic impairment. 

▶️Therefore, it is the interaction of raised  ICP with other intracranial pathology which produces the pathologic consequences, as  opposed to the rise in ICP per se.  

Monitoring of intracranial pressure (ICP)
➖➖➖➖➖➖➖➖➖➖➖➖➖➖

📛"Some patients with suspected intracranial hypertension and a decreasing level of consciousness might require invasive ICP monitoring, although its added value beyond clinical or radiological monitoring has not yet been proven"

📛Monitoring methods currently available include ventriculostomy, subarachnoid bolt, epidural sensor, and fiberoptic intraparenchymal monitor; the latter is the most commonly used.

▶️DO YOU KNOW?

📛The major drawback of intraventricular catheters is the rate of infection which is much higher than that observed using intraparenchymal probes. 

📛Additionally, interpretation of ICP data after craniectomy is difficult.

Monitoring of CBF
➖➖➖➖➖➖➖

▶️Normal average CBF in the human is approximately 55 ml/100g (of brain)/min, though values may vary widely across grey and white matter. The ischemic threshold for CBF is approximately 18 ml/100g/min, with 10 ml/100g/ min often considered the threshold for irreversible injury. 

📛Laser Doppler flowmetry (LDF) is a parenchymal or surface Doppler probe that measures tissue local CBF in a quantitative manner. 

📛Brain tissue oxygen tension (P bt O 2 ) monitoring allows direct measurement of focal tissue oxygen tension in a specific region of the brain. A P bt O 2  level below 10-15 mmHg has generally been the threshold identified at which outcome is worsened 

📛 Transcranial Doppler ultrasonography is a useful non-invasive monitor of cerebral hemodynamics, but has been severely disadvantaged by the inability to fix the  probe in position. 

 📛 Jugular venous bulb oximetry is a global hemispheric measure with low sensitivity for detecting regional ischaemia. 

🔹The normal SjvO 2  level is approximately 60%
🔹an SjvO 2  of < 50% for greater than 10 min has generally been considered to represent an ischemic desaturation. 
🔹High SjvO 2 levels may reflect hyperemia (typically >90%) or an inability of the brain to extract oxygen due to metabolic depression from sedative agents, poor oxygen unloading (e.g. sickle cell disease), or severe brain injury. 

📛Near-infrared spectroscopy (NIRS) 

🔹measures cerebral regional oxygen saturation by measuring near-infrared light reflected off the chromophobes in the brain, the most important of which are oxyhemoglobin, deoxyhemoglobin, and cytochrome A3. 
🔹Its major limitations include the intersubject variability, the variable length of the optical path, the potential contamination from extracranial blood, and most important, the lack of a definable threshold. 🔹Because of the thin scalp and skull in the neonate and infant, NIRS holds promise in this patient population but remains an investigative tool in its present form.

📛Microdialysis catheters, typically inserted in conjunction with an ICP or tissue Po2 monitor, allows sampling of small molecules in the interstitial fluid. 

🔹An increasing lactate/pyruvate ratio is sensitive to the onset of ischemia. 
🔹High levels of glycerol suggest inadequate energy to maintain cellular integrity and the resultant membrane breakdown. 
🔹Excitatory amino acids, such as glutamate, are both a marker for neuronal injury and a factor in its exacerbation.
🔹Currently, the microdialysis catheter is primarily used in two situations: (a) extensive subarachnoid hemorrhage where subsequent vasospasm is likely and (b) traumatic brain injury (TBI) 

▶️️At present, none of the methods available is sufficiently reliable or well tested to en able us to influence the clinical management of neurologically i njured patient with absolute certainty


➖➖➖➖➖➖➖➖➖➖➖➖➖➖➖➖➖➖➖

Reference:

Advanced cerebral monitoring in neurocritical care Nobl Barazangi, J. Claude Hemphill III, eurology India | October-December 2008 | Vol 56 | Issue 4

Intraoperative Neurophysiological Monitoring Second Edition Aage R. Møller

Postoperative management of adult central neurosurgical patients: Systemic and neuro-monitoring David Pfister, Stephan P. Strebel , Basel, Switzerland Luzius A. SteinerBest Practice & Research Clinical Anaesthesiology Vol. 21, No. 4, pp. 449–463, 2007 

Textbook of Neuroanaesthesia and Critical Care by Basil F Matta

Handbook of Neuroanesthesia, 4th Edition, James E. Cottrell